We often talk about the bad viruses that cause #COVID19, the #flu and the common cold, but are all viruses bad? 🧟♂️ Watch the latest episode of #CoffeeBreakScience, featuring Diana Wing Y Lee, to find out! 🔎
Moderna
Biotechnology Research
Cambridge, Massachusetts 580,815 followers
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
About us
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
- Website
-
https://www.modernatx.com/?tc=soc_7y8qkt&cc=1004
External link for Moderna
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2010
- Specialties
- Biotechnology and mRNA Therapeutics
Locations
-
Primary
200 Technology Sq
Cambridge, Massachusetts 02139, US
-
1 Upland Rd
Norwood, Massachusetts 02062, US
Employees at Moderna
-
Jean-Christophe Wüthrich
Business Technology Management | Strategic Planning & IT Governance | Service Management, Integration & Performance | Change Management | Sourcing…
-
Shawn Lipstein
Innovative UX Leader | Critical Design Thinker | Strategic Visionary | Empathetic Manager | Driven Partner | Crystal Clear Communicator
-
Lukasz Wielochowski
Head of Moderna Enterprise Solution Hub in Poland
-
Karen Doolittle
Associate Director, Pharmacovigilance Operations - Project Management (PgMP/PMP)
Updates
-
Long COVID is having a major impact on the productivity of health systems and the wider workforce. One recent estimate suggests that #LongCOVID may have cut labor supply in the European Union by more than 1 million full-time workers in 2022. Studies in the US and UK have reached similar conclusions, indicating that the condition has driven the recent increase in workplace absence in many countries. Read more in this article from Financial Times: https://lnkd.in/gJsXgdWd
-
In celebration of #AAPIHeritageMonth, we're proud to share the stories from our Asian and Pacific Islander colleagues across Moderna, leading at home, at work, and in their communities, and helping to positively impact human health. Meet Saad Sohail from our Platform Chemistry Group, a Senior Research Associate with a focus on advancing our #mRNA and #LNP platforms. Saad was born in High Point, North Carolina, and spent much of his childhood living throughout the Middle East and South Asia, including Pakistan, India, Iraq, Iran, Turkey, Afghanistan, and the UAE. He completed his undergraduate and graduate degrees at the University of North Carolina, Greensboro, and moved to Massachusetts to pursue a career in medicinal chemistry. When he's not in the lab, he's spending time in the company of friends and loved ones, or volunteering with community outreach programs. His advice to young Asian professionals: "Express a bit more grace to yourself as it is often something that is difficult to do – especially in our most vulnerable moments!"
-
Your risk of #LongCOVID rises with each additional infection. A recent study has shown that by their third COVID infection, patients have a 40% chance of developing Long COVID symptoms. Learn more about the threat of Long COVID: https://lnkd.in/e__eGt8n
Risk of Long COVID
-
Our obsession with learning is as boundless as the universe! 🌌🚀 Last week, we had the great pleasure of welcoming representatives from NASA - National Aeronautics and Space Administration and the International Space Station National Laboratory at our new Moderna headquarters in Cambridge, Massachusetts, to learn about #biomedical research in space and bring new perspectives to our thinking, as we continue to advance our science and our business. Thank you to NASA astronaut Stephen Bowen who inspired all of us with his experience living and working at the International Space Station, as well as Jorge Sotomayor and Dr. Davide Marotta, Ph.D., who delighted us with the ISS’s capabilities and research.
-
For the second episode of Coffee Break Science we sit down with Nathen Bopp, a Senior Scientist in our Antigen Design and Selection team, to understand what #vaccines are, and how they help our immune system fight infectious diseases. 💪🏽🤺 Grab your coffee, watch the video below, and follow the hashtag ➡ #CoffeeBreakScience
-
In our latest #IRInsights video, members of our executive team sat down to recap this morning’s earnings report for the first quarter of 2024, and provide more insight into upcoming pipeline milestones, and exciting clinical and corporate developments happening at Moderna. Watch the full video: https://lnkd.in/gPwV4iyK
IR Insights: Recapping our Q1 2024 Earnings Report
-
Today, we reported financial results and provided business updates for the first quarter of 2024. Read more: https://lnkd.in/gjG5EP4k
-
We’ve just concluded an enriching four days at the ESCMID - European Society of Clinical Microbiology and Infectious Diseases Global Congress in Barcelona. Thank you to everyone who joined us! Here are some highlights from Moderna at ESCMID: 🧬 Presented nine presentations, including two late-breaker oral presentations, two oral presentations, and five poster presentations. 🛡️ Advanced Vaccine Research: Shared key research on the utilization of mRNA technology across multiple infectious disease areas, including COVID-19, #influenza, and respiratory syncytial virus (#RSV), in addition to advancing research in the area of #cytomegalovirus. 🗨️ Integrated Symposium Success: Our session on a multi-dimensional perspective on the adult burden of respiratory illness and how mRNA science plays a role was a standout, drawing insights into how mRNA science is transforming healthcare. We are inspired by our conversations and the potential collaborations that await. Together, we are advancing mRNA research across infectious diseases. #ESCMIDGlobal2024
-
Earlier this month, Moderna, People.Health and community organizations came together to open a mobile clinic in Detroit that provides free lung CT screenings, and evaluate patients for possible lung damage caused by various risk factors. For the latest episode of Podnosis, Anastassia Gliadkovskaya sat down with James A. Mansi, our Vice President of Medical Affairs and Sandra Carey, President of People.Health to discuss how the clinic collaborates with community-based organizations and other healthcare providers to carry out its work. Listen to the full podcast below 🎙🎧 https://lnkd.in/eg7x3rdM
'Podnosis': A mobile clinic, free scans and the search for long COVID answers
fiercehealthcare.com